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Abstract This paper discusses the development of engi-
neering controls and automation strategy required to
practically implement a Control Strategy within a Quality
by Design environment. It describes the relationship to the
ISPE PQLI Control Strategy model, and covers operating
philosophy, record keeping, data management, and alarm
strategy. Engineering and automation controls may include
measurement technologies for equipment parameters (off-
line, at-line, in-line or on-line), univariate or multivariate
process models and control models, engineering or plant
procedural controls and automation systems. Concepts from
ANSI/ISA S95 standards are applied.
Keywords PQLI . Design space . Control strategy . Critical
quality attribute . Critical process parameter . Knowledge
space . PAT. Product and process knowledge . Process
model . Control model
Introduction
This paper covers the development of engineering controls
and automation strategy and how they can be applied in the
context of the proposed ISPE PQLI Control StrategyModel as
described in PQLI Control Strategy Model and Concepts
[6] in this volume of the Journal of Pharmaceutical
Innovation and should be read in conjunction with that paper.
The Control Strategy Model aims to facilitate commu-
nication and understanding of the concept and provide a
framework for a structured approach to the development
and implementation of a Control Strategy.
The model seeks to link the attributes of the product that
are important to the patient, to the controls in the manufac-
turing process that are needed to deliver those attributes, and
also to show in parallel the business requirements. The model
shows three levels showing links from the finished product
CQAs and other objectives through the manufacturing
operations to the controls by which these are achieved.
At Control Strategy Level 1 the Critical Quality
Attributes (CQAs) and other requirements are identified.
Level 2 considers the critical process parameters, material
attributes and components involved in meeting the CQA
requirements. Level 3 covers the actual analytical, automa-
tion, and other controls of the Level 2 identified parameters
and attributes. This paper focuses on the development of
engineering and automation controls at Level 3.
The engineering control and automation strategy
describes how the process will be controlled and documents
the principles of verification to ensure that the product
meets both patient critical and business requirements, and
that the process has been operated in control within the
approved Design Space.
The process model defines what the process require-
ments are whereas the control model is concerned with how
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these requirements are achieved. The control model
manages the dynamics of process changes in real time.
Note that the terms Control Strategy Levels 1, Level 2,
and Level 3 as used in the PQLI Control Strategy Model
are different to the ISA levels referred to later in this paper.
This should be regarded as work in progress and
comment and input from industry, regulators, and suppliers
is welcomed.
Analytical, Engineering, and Other Control Methods
Consideration of analytical, engineering and automation
controls can begin when the Level 2 strategies are well
developed. The CQAs and any associated critical and non-
critical process parameters will have been identified and a
manufacturing route established. The production data required
to assure that the product meets all regulatory, safety, efficacy,
and GMP quality requirements should have been identified.
Other key performance requirements that relate to
business needs such as minimising costs, maximising
yields, etc while operating within the Design Space should
also have been identified.
The Level 3 Control Strategy for engineering and
automation controls defines how the Level 2 requirements
will be implemented. Examples include measurement
technologies for equipment parameters (off-line, at-line,
in-line or on-line), univariate or multivariate process
models and control models, engineering or plant procedural
controls, and automation systems.
Operating Philosophy
The approach taken will depend on the firm’s approach to
lifecycle management for the particular product, e.g.
whether the product is to be accommodated in an existing
manufacturing plant possibly requiring modifications, or a
new plant is to be designed and built. If the product is to be
manufactured in a new plant, this gives an opportunity to
develop or revise a high level operating philosophy.
Considerations may include:
& How will the risks identified at Level 1 and Level 2 be
mitigated?
& How will the production workflow be managed1?
& How will manufacture of the product be integrated with
other systems such as Manufacturing Execution Sys-
tems, Materials Management Systems, or Production
Scheduling Systems?
& How will the Critical Process Parameters (CPPs) be
maintained in control within the process Design Space
during the manufacturing process?
& How will the production data be collected and monitored
to verify that all CQAs are achieved for the product?
& How will the site quality system ensure that the product
meets its specifications to ensure product safety,
efficacy and quality?
ISA-95
The ISA-95 international standards for the integration of
enterprise and control systems [1–4] are a useful tool when
establishing an operating philosophy. ISA-95 consists of a
framework (Fig. 1) and terminology.
These can be used to determine which information has to
be exchanged between systems for sales, finance and
logistics and systems for production, maintenance and
quality assurance.
The ISA S95 Function diagram describes the activities
that must take place in order to produce a product. They
represent the business processes required for manufacturing
to take place. Activities would typically occur from left to
right in Fig. 2 and the boxes from top to bottom shows the
levels of integration between levels.
The ISA S95 framework can be used to define a high level
operating philosophy and to summarise and document how
each activity will be implemented. Some activities may be
manual processes supported by Standard Operating Proce-
dures (SOPs), while others may be implemented using
commercial software for engineering control and automation.
The operating philosophy for drug substance (DS) and
drug product (DP) may be different. For example, the
operating philosophy for drug substance manufacture may
be to have a central control room with computer based
supervision and control with high levels of automation. The
operating philosophy for drug product may be to have
independent but automated process stages with progression
from stage to stage by means of a paper based batch sheet
or a Manufacturing Execution System.
If a product (DS or DP) has been developed using
enhanced product development and Quality by Design
(QbD) principles then product, process, science and
chemical engineering knowledge may be applied to
produce process models for key process stages.
These process models define the relationship between
process variables and may include heat and mass balances.
The objective is to predict, model and control the CPPs for
each stage, their acceptable working ranges, and how they
influence product CQAs.
1 Options include using a traditional paper batch sheet, or alternatively
a computer based electronic batch workflow system incorporating
electronic signatures (in which case relevant regulations such as 21
CFR 11 must be considered)
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Control Models
Control models can then be developed that are designed to
maintain CPPs and other process variables under control
within the Design Space, corresponding to product related
acceptable working limits. In a multi-product plant these
process variable acceptable working limits may vary
between products. The control models are concerned with
the time dependant dynamics of maintaining process
variables within acceptable limits, i.e. controlled within
the approved Design Space.
Options available include the following:
& Use traditional recipes and implement changes within
the Design Space with a streamlined validation ap-
proach. This may include focusing only on the affected
variables, limiting validation to changes that are the
edge of the Design Space, or using less than three runs
Fig. 2 The ISA 95 operating philosophy functional framework for activities (note ISA 95 levels are different from PQLI Control Strategy Levels)
Fig. 1 The ISA 95 operating philosophy framework for manufacturing (note ISA 95 levels are different from PQLI Control Strategy Levels)
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for validation based on knowledge-rich areas within the
Design Space.
& Allow the plant to select optimization mode by running a
particular predefined recipe that assures acceptable CQAs
based on incoming material quality attributes (e.g. select-
ing a recipe based on particle size distribution from the
previous milling step or a raw material vendor.)
& Incorporation of recipe parameter adjustments within a
predefined recipe based on incoming material quality
attributes.
& Implement a multivariate control model to update set-
points to operate within the design space.
& Make the Design Space knowledge available to the
plant to help them utilize the new set-point freedom to
achieve manufacturing objectives (e.g. reduce cycle
time or increase yield)
Underpinning many of the options above will be
information gained by tracking and trending of the
manufacturing process on a batch-by-batch basis. Currently
operators typically only have access to information about
the current batch.
Control Strategy
Controls may have to handle non-contiguous operating
regions. Most control systems allow one set of set-point
limits on a parameter. If there were 3 interacting CPPs, how
could an operator jump to a new operating region? This is a
problem to consider for control system programming, and
in the longer term by control system vendors.
The DS/DP manufacturing Design Space is identified
during product development and measurement tech-
niques for the CPPs are developed. Many will be based
on traditional univariate measurements such as tem-
perature, flow, and pressure but some may require multi-
variate measurements such as spectroscopy. In either
case the proposed technology should be defined and
documented.
Some multivariate techniques such as near infrared
(NIR) spectroscopy may not provide a direct measure-
ment of the process parameter of interest. In order to
successfully use these techniques it is necessary to
conduct an experimental programme (Design of Experi-
ment - DOE) taking spectra and process samples; then
analysing them using a reference method performed on
traditional laboratory instruments e.g. Chromatography or
Karl- Fisher.
Chemometric modelling can then be applied to the
spectra and reference analysis data to determine if a
correlation exists between the reference results and one or
more cases of absorbance at specific wavelengths. These
activities result in a process model that is analogous to the
chemical engineering process models described earlier.
Models will need to be validated usually through the use
of a set of independent measurements and samples.
Multivariate analysis techniques will need to be trans-
formed into a practical engineering solution before being
used in manufacturing. This may include risk assessments,
design of sampling system, integration with the process
control system, and data management. The control model
includes the real time execution of the process model to
produce univariate estimates that can be used by the process
control system to maintain the process parameter within its
acceptable working limits.
For example, a NIR spectrometer may be used to
monitor material in a fluid bed dryer and the estimated
water content used by the process control system to stop the
drying process when the material has reached the desired
moisture level.
There should be traceability from each CQA to
associated CPPs and to the instruments that provides
direct or indirect measurement. This information may be
included in a critical instrument register so as to ensure
that they are regularly tested or calibrated and main-
tained. These instruments should be covered during risk
assessment.
The information obtained from process modelling and
process equipment design can be used to define an
operating alarm philosophy. For example, safety related
(operator and equipment) alarms could be classified
separately from product related alarms associated with
CQAs and CPPs.
Record Keeping and Data Management
There are stringent requirements for regulatory record
keeping. Records for regulatory compliance and product
release are usually managed by the Quality Unit. The
knowledge-rich enhanced pharmaceutical development ap-
proach may require much more data to be collected and
managed to enable continual process improvement during
the product lifecycle. This data is likely to include
traditional univariate process variables such as flows or
temperatures, but may also include multivariate data like
particle size distributions and spectra. The alignment of
time-stamps and the ability to relate various unit operations
via batch ID is necessary for later data analysis.
Data can be collected in an ad-hoc manner from
individual process equipment and combined with batch
record data to satisfy the quality and GMP requirements,
but this does not necessarily facilitate using the data for
process improvement and analysis of any batch to batch
variations.
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A strategic data management framework that supports
both types of data may be described based on the ISA-95
standard (see Fig. 3).
ISA-S95 Level 1 – Process Sensing and Manipulation
ISA 95 Level 1 consists of traditional measurement
equipment for univariate process variables (e.g. flow,
temperature, or pressure) and more advanced instrumenta-
tion for the determination of process or material physical
and chemical properties. The latter often result in multivar-
iate data from instruments such as spectrometers and
particle size measurement systems. These instruments may
require additional supporting systems for performance
monitoring and standardisation to ensure successful and
reliable long-term operation. ISA 95 Level 1 also consists
of actuators or devices to manipulate the process but this is
outside the scope of this paper.
ISA-S95 Level 2 – Monitoring and Control
of the Process
ISA 95 Level 2 systems are of particular interest as they
form a bridge between analytical and process measurement
systems and data management and modelling systems.
Process monitoring and control is well established and
implemented using Supervisory Control and Data Acqui-
sition (SCADA) systems together with programmable
logic controllers (PLCs). Distributed Control Systems
(DCS) are also used. These systems can connect to sensors
from many different vendors and mainly deal with
univariate process variables and simple raw data trans-
formations. This provides visualisation of the process and
allows controlled interaction with the process via the
control system.
Sensor and instrument management and control should
allow the setup of Process Analytical Technology (PAT)
instruments from different vendors and support the creation
and execution of complex analytical methods or workflows.
The workflow should allow control of the PAT instruments
and use of the multivariate data obtained, together with real
time chemometric prediction engines to calculate scalar
prediction variables that can be used by the associated
process monitoring and control system.
The management of the multivariate raw data and
associated prediction variables is critical and will require
metadata to describe the context of the measurement(s)
made. In the simplest case this will be software provided
by the vendor to operate a specific instrument. Major
challenges include lack of multivariate data exchange
standards, file structure standards, instrument control
standards and interfacing to process monitoring and
control systems.
Alarm Management
If a CPP goes outside the normal operating range, the
operator should be notified and the event logged and
addressed as required by the Quality System. Automatic
actions may be appropriate such as putting the process on
hold, shutting down the process or possibly diverting
material to scrap if outside the approved Design Space.
Like set point limits, alarm limits may need to take the
Design Space into account. Alarm limits may need to be
dynamically adjusted for individual CPPs to match the
specific normal operating range. This is more complicated
than static steady state limits and more similar to phase
specific alarm limits for handling start-up and shutdown
sequences.
Warning limits inside the normal operating ranges are
also desirable. Actions on these warnings would be
process and plant specific. If the process leaves the
Design Space, the Quality System should define the
appropriate actions.
If isolated operating regions exist, and transitions between
regions are allowed during processing, alarm suppression
during the transition is a consideration, as is a control plan to
manage the transition and impact on product.
Outputs such as charts showing the process is operating
in control within the Design Space over time are helpful for
investigations and trending.
ISA-S95 Level 3 – Data Management Systems
and Historians
ISA Level 3 PAT data management systems should include
support for multivariate analytical method development.
This in turn generates requirements for managing laborato-
Fig. 3 Data management framework based on ISA 95 standard (Note
ISA 95 levels are different from PQLI Control Strategy Levels)
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ry reference data, integration with chemometric modelling
software and management of models.
There is little guidance on how this data can be
identified, indexed, searched or otherwise used for method
development, making predictions or generating GMP
related reports.
Metadata, such as the context in which a measure-
ment has been made, is important in PAT data
management. Means should therefore be provided to
generate and maintain the metadata associated with the
measurements.
PAT data management should not be considered in
isolation. It may form part of a larger technology
infrastructure that includes process control and automation.
Decisions should be based on an understanding of the
overall technology infrastructure for development and
manufacturing.
ISA-S95 Level 4 – Business Planning and Logistics
ISA Level 4 systems are typically used for establishing the
basic plant schedule, production, material use, and inven-
tory levels.
In the context of PAT and enhanced process develop-
ment, there are various possibilities in the areas of
real-time release and knowledge management (a
systematic approach to acquiring, analyzing, storing
and disseminating information related to products,
processes and components as defined by the ICH Q10
EWG). In the future this may be achieved through the
use of information technology portals2.
Example of Process Model and Control Model
See also Fig. 4 above.
1. A reaction stage of a drug substance manufacturing
process, requires a fixed mass of Liquid A to be
charged into a reactor.
2. Liquid A should be heated until it reaches a steady state
temperature of 30 Deg C.
3. A matching molar quantity of Liquid B should be
charged into the reactor at a rate of 1 Kg/Min.
4. An exothermic reaction occurs and the temperature
must not exceed 40 Deg C
2 A portal is a framework for choosing, displaying and navigating
among diverse infospaces. (e.g. a user configurable Web page set up
for batch release). An infospace is a collection of portlets intended to
support a particular role, business process or area of knowledge, e.g. a
PAT infospace. A portlet is a clearly defined collection of information,
presented in a window and reusable in different contexts and views, e.g.
PAT measurements associated with a specific product/formulation and
batch.
Fig. 4 Process example
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The process model would require knowledge of the
chemical and physical properties of the liquids and thermo-
dynamic properties of the reaction so that the heat of reaction
could be calculated and the temperature rise predicted.
From this modeling, a decision on using a jacketed
reactor was taken.
Further process modeling taking into account the surface
area of the jacket, the heat transfer fluid used and the rate at
which the heat of reaction could be removed from the
reactor made it necessary to include a heat/cool/chill system
in the plant design.
The control model defines how the requirements of the
process model could be met.
Risk assessments would be applied to ensure that all control
activities could take place in a safe and effective manner.
For a batch process the principles contained in the ISA
S88 [5] batch control standard would be followed.
In this example the quantity of liquid B to be charged
could be calculated based on the actual mass of liquid A
that was charged. The control model would include checks
to ensure that there was sufficient capacity in the reactor to
receive the charge. The control system would know which
plant valves needed to be opened to establish a route from a
storage tank to the reactor. During the transfer it would
continuously monitor the level in the reactor to ensure it
was not overfilled.
How could the reactor temperature be maintained? In
one scenario, the control model would compare the actual
temperature of the reactor contents with the required
temperature and adjust the temperature of the heat transfer
fluid to minimize the error. The temperature of the heat
transfer fluid could be adjusted by diverting the fluid
through chilling, cooling or heat exchangers.
References
1. ANSI/ISA-95.00.01–2000, Enterprise-Control System Integration,
Part 1: Models and Terminology,
2. ANSI/ISA-95.00.02–2001, Enterprise-Control System Integration,
Part 2: Object Model Attributes, contains additional details and
examples to help explain and illustrate the Part 1 objects.
3. ANSI/ISA-95.00.03–2005, Enterprise-Control System Integration,
Part 3: Activity Models of Manufacturing Operations Management,
presents models and terminology for defining the activities of
manufacturing operations management.
4. ANSI/ISA-95.00.05–2007, Enterprise-Control System Integration,
Part 5: Business-to-Manufacturing Transactions, defines the trans-
actions to interface business and manufacturing activities.
5. ANSI/ISA S88.01–1995, Batch Control Part 1: Models and
Terminology
6. PQLI Control Strategy Model and Concepts DOI 10.1007/s12247-
008-9035-1
If you would like to provide comments to the authors regarding this
paper, email feedback@ispe.org and include “PQLI Engineering
Controls” in the subject line.
94 J Pharm Innov (2008) 3:88–94
